Jianfeng Shen
- Oncology top 5%
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Molecular Biology top 10%
- Chromatin Remodeling and Cancer 7
- DNA Repair Mechanisms 6
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 4
- Immunology top 10%
- interferon and immune responses 12
- Reproductive Medicine top 5%
-
- Cancer Mechanisms and Therapy 6
- Co-authors
- Guang PengYang PengGordon B. MillsZhenlin JuLulu WangTimothy A. YapWei ZhaoMarilyne Labrie
- Journals
- Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Jianfeng Shen
59 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 742
- Cancer Research 359
- Molecular Biology 1.2k
- Immunology 363
- Reproductive Medicine 136
Countries citing papers authored by Jianfeng Shen
This map shows the geographic impact of Jianfeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Shen more than expected).
Fields of papers citing papers by Jianfeng Shen
This network shows the impact of papers produced by Jianfeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Shen. The network helps show where Jianfeng Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianfeng Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 4 | |
| 15 | 2019 | 2 | |
| 16 | PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAnessbreakdown → | 2018 | 427 |
| 17 | 2018 | 45 | |
| 18 | ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitorsbreakdown → | 2015 | 358 |
| 19 | 2015 | 164 | |
| 20 | Comparison Of Pro-apoptotic Effects Of Avastin And Lucentis In Rat Primary Neuronal Cells | 2012 | 1 |
About Jianfeng Shen
Jianfeng Shen is a scholar working on Cancer Research, Immunology and Structural Biology, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include interferon and immune responses (12 papers), Chromatin Remodeling and Cancer (7 papers), DNA Repair Mechanisms (6 papers), Cancer Mechanisms and Therapy (6 papers), RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers), MicroRNA in disease regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Oncology (742 citations), Cancer Research (359 citations) and Molecular Biology (1.2k citations). Jianfeng Shen has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Guang Peng, Yang Peng, Gordon B. Mills, Zhenlin Ju, Lulu Wang, Timothy A. Yap, Wei Zhao, Marilyne Labrie, Prabodh Kapoor and Iván P. Uray. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.